Cindy Reiss-Clark - 18 Feb 2025 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
Chief Commercial Officer
Signature
/s/ Louis Lalli, as an agent for Cindy Reiss-Clark
Issuer symbol
WST
Transactions as of
18 Feb 2025
Net transactions value
+$34,389
Form type
4
Filing time
20 Feb 2025, 21:16:49 UTC
Previous filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $51,940 +246 +5% $211.00 5,131 18 Feb 2025 Direct
transaction WST Common Stock Tax liability $17,551 -83 -1.6% $211.00 5,047 18 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Option (Right to Buy) Award $0 +1,162 $0.000000 1,162 18 Feb 2025 Common Stock 1,162 $211.00 Direct F1
transaction WST Rst. Stock Unit Award $0 +503 $0.000000 503 18 Feb 2025 Common Stock 503 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in four equal installments beginning on February 18, 2026.